Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × palbociclib × Sarcoma × Clear all

Phase

Status

Completed 5 Active not recruiting 5 Recruiting 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 23 Dermatologic 3 Tumor-Agnostic 2 Thoracic 2 Head & Neck 2 Genitourinary 2 Gastrointestinal 2 Sarcoma 1 Gynecologic 1 CNS 1

Conditions

Sarcoma 1 Osteosarcoma 1 Chordoma 1

Interventions

Doxorubicin 19 Radiotherapy 15 Cyclophosphamide 15 Ifosfamide 12 apatinib 11 anlotinib 11 Imatinib Mesylate 9 Vincristine 8 Temozolomide 8 Surgical Procedures, Operative 7 Drug Therapy 7 camrelizumab 6 Methotrexate 6 Dactinomycin 5 fludarabine phosphate 4 Paclitaxel 4 Neoadjuvant Therapy 4 Etoposide 4 Docetaxel 4 Carboplatin 4 toripalimab 3 pembrolizumab 3 Trabectedin 3 Topotecan 3 Surveys and Questionnaires 3 Nivolumab 3 Melphalan 3 Laparoscopy 3 Irinotecan 3 Endoscopic Mucosal Resection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03242382 2024-01-23

PalboSarc

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown

Chordoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡